High levels of estradiol, BRAFV600E, or epidermal growth factor (EGF), which are associated with breast cancer, melanoma, and non-small cell carcinoma (NSCLC), respectively, were found to regulate PFKFB3 expression [10,58,172]. This evidence concerns the gene EGF and breast carcinoma.